The association between Neurofibromatosis type I (NF1) and multiple myeloma (MM), a plasma cell, dyscrasia is very rare. Here we put to the attention of the scientific community two new cases. The first one is a patient with active MM whereas the second with smoldering MM. Both patients present typical features of NF1 but skeletal alterations were present only in the second case including dysplasia, marked scoliosis and osteoporosis. MM osteolytic lesions were absent in both patients. In addition to the clinical diagnosis of NF1, a molecular testing for NF1 gene mutations has been performed finding that patient one was heterozygous for the c.6855C>A (Tyr2285Ter) mutation, while patient two was heterozygous for the c.7838dupC (Lys2614GlufsTer20) mutation. The two mutations were diagnosed both in genomic DNA from peripheral blood and from MM cells. The potential link between NF1 mutation and the increased risk of MM is discussed in the report.
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? / Accardi, Fabrizio; Marchica, Valentina; Mancini, Cristina; Maredi, Elena; Racano, Costantina; Notarfranchi, Laura; Martorana, Davide; Storti, Paola; Martella, Eugenia; Palma, Benedetta Dalla; Craviotto, Luisa; de Filippo, Massimo; Percesepe, Antonio; Aversa, Franco; Giuliani, Nicola. - In: HEMATOLOGY REPORTS. - ISSN 2038-8330. - 10:1(2018), pp. 23-26. [10.4081/hr.2018.7457]
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Accardi, Fabrizio;Marchica, Valentina;RACANO, COSTANTINA;Martorana, Davide;Storti, Paola;Palma, Benedetta Dalla;Craviotto, Luisa;de Filippo, Massimo;Percesepe, Antonio;Aversa, Franco;Giuliani, Nicola
2018-01-01
Abstract
The association between Neurofibromatosis type I (NF1) and multiple myeloma (MM), a plasma cell, dyscrasia is very rare. Here we put to the attention of the scientific community two new cases. The first one is a patient with active MM whereas the second with smoldering MM. Both patients present typical features of NF1 but skeletal alterations were present only in the second case including dysplasia, marked scoliosis and osteoporosis. MM osteolytic lesions were absent in both patients. In addition to the clinical diagnosis of NF1, a molecular testing for NF1 gene mutations has been performed finding that patient one was heterozygous for the c.6855C>A (Tyr2285Ter) mutation, while patient two was heterozygous for the c.7838dupC (Lys2614GlufsTer20) mutation. The two mutations were diagnosed both in genomic DNA from peripheral blood and from MM cells. The potential link between NF1 mutation and the increased risk of MM is discussed in the report.File | Dimensione | Formato | |
---|---|---|---|
hr-10-1-7457.pdf
accesso aperto
Tipologia:
Versione (PDF) editoriale
Licenza:
Creative commons
Dimensione
181.72 kB
Formato
Adobe PDF
|
181.72 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.